US Stock MarketDetailed Quotes

ADCT ADC Therapeutics

Watchlist

4.900
+0.170+3.59%

Close May 3 16:00 ET

4.900
0.0000.00%

Post 16:00 ET

405.79MMarket Cap-1666P/E (TTM)

ADC Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

14.19%-118.69M

38.31%-33.07M

-1,649.75%-34.02M

30.53%-36.83M

56.40%-14.77M

40.74%-138.31M

13.01%-53.61M

103.75%2.2M

8.62%-53.01M

38.56%-33.88M

Net income from continuing operations

-52.78%-240.05M

-236.29%-85.7M

5.53%-47.81M

26.81%-47.12M

-256.68%-59.43M

31.69%-157.13M

25.87%-25.49M

29.27%-50.61M

11.29%-64.37M

67.67%-16.66M

Operating gains losses

-89.39%4.32M

-37.92%2.6M

-97.65%756K

-51.47%858K

-95.66%109K

564.72%40.69M

82.46%4.18M

1,351.94%32.23M

28.58%1.77M

968.51%2.51M

Depreciation and amortization

36.81%3.27M

58.96%1.01M

38.64%793K

31.23%769K

16.84%694K

-9.20%2.39M

-16.21%636K

-13.07%572K

-7.72%586K

2.77%594K

Deferred tax

2,388.96%37.1M

671.58%45.75M

-231.07%-578K

-74.53%-7.22M

78.01%-848K

93.78%-1.62M

122.76%5.93M

--441K

---4.14M

---3.86M

Other non cash items

168.11%17.3M

-28.95%-6.1M

-42.75%8.3M

233.81%12.01M

111.85%3.1M

-48.97%-25.41M

49.54%-4.73M

30.12%14.49M

-2,395.40%-8.98M

-36.38%-26.19M

Change In working capital

190.86%44.27M

117.26%10.18M

104.82%224K

-98.48%251K

2,267.31%33.62M

-210.15%-48.73M

-972.28%-59M

66.05%-4.65M

853.36%16.47M

-187.93%-1.55M

-Change in receivables

211.78%47.79M

91.95%-4M

211.53%2.7M

-96.81%188K

1,310.88%48.9M

-41.48%-42.75M

-246.94%-49.69M

82.49%-2.42M

383.26%5.89M

--3.47M

-Change in inventory

40.81%-5.71M

90.53%-332K

-77.19%-3.3M

51.52%-1.9M

50.70%-175K

-219.36%-9.65M

-69.95%-3.51M

-26,714.29%-1.86M

-306.52%-3.93M

---355K

-Change in payables and accrued expense

-166.26%-10.97M

-175.60%-9.26M

-74.59%849K

132.26%1.1M

-183.57%-3.66M

-14.29%16.56M

25.38%12.25M

93.79%3.34M

-278.50%-3.41M

-25.89%4.38M

-Change in other current assets

164.15%7.49M

166.41%8.08M

61.55%-1.27M

-87.06%629K

105.16%55K

-83.67%-11.67M

-310.77%-12.16M

-88.06%-3.31M

279.34%4.86M

-199.07%-1.07M

-Change in other current liabilities

571.74%5.68M

366.67%15.69M

-55.37%2.44M

-103.73%-368K

-13.35%-12.09M

---1.2M

---5.88M

--5.47M

--9.88M

-100.04%-10.67M

-Change in other working capital

----

-81.02%605K

-78.15%587K

----

1,228.33%3.19M

2,410.28%2.69M

Cash from discontinued investing activities

Operating cash flow

14.19%-118.69M

38.31%-33.07M

-1,649.75%-34.02M

30.53%-36.83M

56.40%-14.77M

40.74%-138.31M

13.01%-53.61M

103.75%2.2M

8.62%-53.01M

38.56%-33.88M

Investing cash flow

Cash flow from continuing investing activities

-368.12%-3.22M

-130.93%-527K

-160.24%-661K

-46.88%-1.01M

29.83%-1.02M

89.70%-687K

305.30%1.7M

89.14%-254K

75.81%-689K

-120.40%-1.45M

Net PPE purchase and sale

-368.12%-3.22M

-61.68%-346K

-241.24%-662K

-2,324.00%-1.21M

-334.93%-996K

79.97%-687K

49.05%-214K

86.19%-194K

94.73%-50K

65.14%-229K

Net intangibles purchase and sale

----

101.67%1K

--0

97.75%-20K

----

93.57%-60K

60.05%-759K

---889K

Net other investing changes

----

--0

----

--0

--120K

---330K

Cash from discontinued investing activities

Investing cash flow

-368.12%-3.22M

-130.93%-527K

-160.24%-661K

-46.88%-1.01M

29.83%-1.02M

89.70%-687K

305.30%1.7M

89.14%-254K

75.81%-689K

-120.40%-1.45M

Financing cash flow

Cash flow from continuing financing activities

8,335.79%73.88M

159.56%1.64M

-197.55%-2.31M

29,758.33%74.74M

24.03%-196K

-100.34%-897K

-125.94%-2.75M

-98.92%2.37M

-100.51%-252K

13.13%-258K

Net issuance payments of debt

--0

-53.54%866K

-100.36%-409K

-3.57%-261K

24.03%-196K

137.79%115.6M

906.93%1.86M

49,987.77%114.24M

-100.51%-252K

14.00%-258K

Net common stock issuance

--0

----

--6.13M

---62K

----

Proceeds from stock option exercised by employees

--773K

----

--0

----

Net other financing activities

159.61%73.1M

--0

---1.9M

----

-156.25%-122.62M

-264.61%-4.55M

----

Cash from discontinued financing activities

Financing cash flow

8,335.79%73.88M

159.56%1.64M

-197.55%-2.31M

29,758.33%74.74M

24.03%-196K

-100.34%-897K

-125.94%-2.75M

-98.92%2.37M

-100.51%-252K

13.13%-258K

Net cash flow

Beginning cash position

-30.03%326.44M

-18.50%310.41M

-7.77%347.51M

-27.93%310.55M

-30.03%326.44M

6.23%466.54M

-28.17%380.86M

1.32%376.78M

12.46%430.87M

6.23%466.54M

Current changes in cash

65.67%-48.03M

41.53%-31.96M

-958.92%-36.99M

168.40%36.9M

55.09%-15.98M

-611.63%-139.9M

14.16%-54.66M

-97.28%4.31M

-379.44%-53.95M

36.57%-35.59M

Effect of exchange rate changes

188.46%184K

-37.45%152K

47.32%-118K

142.07%61K

208.54%89K

-3,566.67%-208K

737.93%243K

-229.41%-224K

-1,066.67%-145K

-373.33%-82K

End cash Position

-14.66%278.6M

-18.50%310.41M

-7.77%347.51M

-27.93%310.55M

-30.03%326.44M

-28.17%380.86M

1.32%376.78M

12.46%430.87M

Free cash flow

12.30%-121.9M

35.92%-33.4M

-1,886.60%-34.68M

29.32%-38.04M

54.89%-15.79M

42.02%-139M

16.16%-52.12M

103.19%1.94M

11.57%-53.82M

37.28%-35M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	14.19%-118.69M	38.31%-33.07M	-1,649.75%-34.02M	30.53%-36.83M	56.40%-14.77M	40.74%-138.31M	13.01%-53.61M	103.75%2.2M	8.62%-53.01M	38.56%-33.88M
Net income from continuing operations	-52.78%-240.05M	-236.29%-85.7M	5.53%-47.81M	26.81%-47.12M	-256.68%-59.43M	31.69%-157.13M	25.87%-25.49M	29.27%-50.61M	11.29%-64.37M	67.67%-16.66M
Operating gains losses	-89.39%4.32M	-37.92%2.6M	-97.65%756K	-51.47%858K	-95.66%109K	564.72%40.69M	82.46%4.18M	1,351.94%32.23M	28.58%1.77M	968.51%2.51M
Depreciation and amortization	36.81%3.27M	58.96%1.01M	38.64%793K	31.23%769K	16.84%694K	-9.20%2.39M	-16.21%636K	-13.07%572K	-7.72%586K	2.77%594K
Deferred tax	2,388.96%37.1M	671.58%45.75M	-231.07%-578K	-74.53%-7.22M	78.01%-848K	93.78%-1.62M	122.76%5.93M	--441K	---4.14M	---3.86M
Other non cash items	168.11%17.3M	-28.95%-6.1M	-42.75%8.3M	233.81%12.01M	111.85%3.1M	-48.97%-25.41M	49.54%-4.73M	30.12%14.49M	-2,395.40%-8.98M	-36.38%-26.19M
Change In working capital	190.86%44.27M	117.26%10.18M	104.82%224K	-98.48%251K	2,267.31%33.62M	-210.15%-48.73M	-972.28%-59M	66.05%-4.65M	853.36%16.47M	-187.93%-1.55M
-Change in receivables	211.78%47.79M	91.95%-4M	211.53%2.7M	-96.81%188K	1,310.88%48.9M	-41.48%-42.75M	-246.94%-49.69M	82.49%-2.42M	383.26%5.89M	--3.47M
-Change in inventory	40.81%-5.71M	90.53%-332K	-77.19%-3.3M	51.52%-1.9M	50.70%-175K	-219.36%-9.65M	-69.95%-3.51M	-26,714.29%-1.86M	-306.52%-3.93M	---355K
-Change in payables and accrued expense	-166.26%-10.97M	-175.60%-9.26M	-74.59%849K	132.26%1.1M	-183.57%-3.66M	-14.29%16.56M	25.38%12.25M	93.79%3.34M	-278.50%-3.41M	-25.89%4.38M
-Change in other current assets	164.15%7.49M	166.41%8.08M	61.55%-1.27M	-87.06%629K	105.16%55K	-83.67%-11.67M	-310.77%-12.16M	-88.06%-3.31M	279.34%4.86M	-199.07%-1.07M
-Change in other current liabilities	571.74%5.68M	366.67%15.69M	-55.37%2.44M	-103.73%-368K	-13.35%-12.09M	---1.2M	---5.88M	--5.47M	--9.88M	-100.04%-10.67M
-Change in other working capital	----	----	----	-81.02%605K	-78.15%587K	----	----	----	1,228.33%3.19M	2,410.28%2.69M
Cash from discontinued investing activities
Operating cash flow	14.19%-118.69M	38.31%-33.07M	-1,649.75%-34.02M	30.53%-36.83M	56.40%-14.77M	40.74%-138.31M	13.01%-53.61M	103.75%2.2M	8.62%-53.01M	38.56%-33.88M
Investing cash flow
Cash flow from continuing investing activities	-368.12%-3.22M	-130.93%-527K	-160.24%-661K	-46.88%-1.01M	29.83%-1.02M	89.70%-687K	305.30%1.7M	89.14%-254K	75.81%-689K	-120.40%-1.45M
Net PPE purchase and sale	-368.12%-3.22M	-61.68%-346K	-241.24%-662K	-2,324.00%-1.21M	-334.93%-996K	79.97%-687K	49.05%-214K	86.19%-194K	94.73%-50K	65.14%-229K
Net intangibles purchase and sale	----	----	101.67%1K	--0	97.75%-20K	----	----	93.57%-60K	60.05%-759K	---889K
Net other investing changes	----	----	--0	----	----	----	----	--0	--120K	---330K
Cash from discontinued investing activities
Investing cash flow	-368.12%-3.22M	-130.93%-527K	-160.24%-661K	-46.88%-1.01M	29.83%-1.02M	89.70%-687K	305.30%1.7M	89.14%-254K	75.81%-689K	-120.40%-1.45M
Financing cash flow
Cash flow from continuing financing activities	8,335.79%73.88M	159.56%1.64M	-197.55%-2.31M	29,758.33%74.74M	24.03%-196K	-100.34%-897K	-125.94%-2.75M	-98.92%2.37M	-100.51%-252K	13.13%-258K
Net issuance payments of debt	--0	-53.54%866K	-100.36%-409K	-3.57%-261K	24.03%-196K	137.79%115.6M	906.93%1.86M	49,987.77%114.24M	-100.51%-252K	14.00%-258K
Net common stock issuance	--0	--0	----	----	----	--6.13M	---62K	----	----	----
Proceeds from stock option exercised by employees	--773K	----	----	----	----	--0	----	----	----	----
Net other financing activities	159.61%73.1M	--0	---1.9M	----	----	-156.25%-122.62M	-264.61%-4.55M	----	----	----
Cash from discontinued financing activities
Financing cash flow	8,335.79%73.88M	159.56%1.64M	-197.55%-2.31M	29,758.33%74.74M	24.03%-196K	-100.34%-897K	-125.94%-2.75M	-98.92%2.37M	-100.51%-252K	13.13%-258K
Net cash flow
Beginning cash position	-30.03%326.44M	-18.50%310.41M	-7.77%347.51M	-27.93%310.55M	-30.03%326.44M	6.23%466.54M	-28.17%380.86M	1.32%376.78M	12.46%430.87M	6.23%466.54M
Current changes in cash	65.67%-48.03M	41.53%-31.96M	-958.92%-36.99M	168.40%36.9M	55.09%-15.98M	-611.63%-139.9M	14.16%-54.66M	-97.28%4.31M	-379.44%-53.95M	36.57%-35.59M
Effect of exchange rate changes	188.46%184K	-37.45%152K	47.32%-118K	142.07%61K	208.54%89K	-3,566.67%-208K	737.93%243K	-229.41%-224K	-1,066.67%-145K	-373.33%-82K
End cash Position	-14.66%278.6M	-14.66%278.6M	-18.50%310.41M	-7.77%347.51M	-27.93%310.55M	-30.03%326.44M	-30.03%326.44M	-28.17%380.86M	1.32%376.78M	12.46%430.87M
Free cash flow	12.30%-121.9M	35.92%-33.4M	-1,886.60%-34.68M	29.32%-38.04M	54.89%-15.79M	42.02%-139M	16.16%-52.12M	103.19%1.94M	11.57%-53.82M	37.28%-35M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall